Page last updated: 2024-08-17

uridine monophosphate and Actinic Reticuloid Syndrome

uridine monophosphate has been researched along with Actinic Reticuloid Syndrome in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beumont, M; Bourgeois, S; Hillewaert, V; Horsmans, Y; Luo, D; Moreno, C; Nevens, F; Ouwerkerk-Mahadevan, S; van de Logt, J; van Eygen, V; Van Remoortere, P; van Vlierberghe, H; Vijgen, L1

Trials

1 trial(s) available for uridine monophosphate and Actinic Reticuloid Syndrome

ArticleYear
Pharmacokinetic Interactions between Simeprevir and Ledipasvir in Treatment-Naive Hepatitis C Virus Genotype 1-Infected Patients without Cirrhosis Treated with a Simeprevir-Sofosbuvir-Ledipasvir Regimen.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:12

    Topics: Adult; Aged; Antiviral Agents; Benzimidazoles; Cytochrome P-450 CYP3A; Drug Interactions; Drug Therapy, Combination; Female; Fluorenes; Hepacivirus; Hepatitis C, Chronic; Humans; Liver-Specific Organic Anion Transporter 1; Male; Middle Aged; Photosensitivity Disorders; Simeprevir; Sofosbuvir; Solute Carrier Organic Anion Transporter Family Member 1B3; Treatment Outcome; Uridine Monophosphate; Viral Load

2017